Showing 48 out of 207 results
FEDERAL COURT OVERTURNS ‘ABSURD’ PATENT OFFICE RULING ON PATENT TERM EXTENSIONS FOR PHARMACEUTICAL SUBSTANCES
The Federal Court has rejected the Australian Patent Office’s historical approach to patent term extension (PTE) applications, upholding a challenge …
Regulatory reform for software-based consumer health - Can rules keep up with reality?
As Australia moves to liberalise oversight of mobile health apps, we ask if such reforms can keep up with changing technology Mobile health apps and …
Herbert Smith Freehills advises sponsors on CARsgen Therapeutics’ HK$3.1 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为科济药业31亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and UBS as joint sponsors of biopharmaceutical company CARsgen Therapeutics …
Australian Consumer Law marks 10 years with some large penalties
The Australian Consumer Law marked its tenth anniversary on 1 January 2021. Some belated presents were recently delivered in the form of the confirmation …
Pharmaceutical patent term extensions: federal court hears challenge to “absurd” Australian patent office ruling
Two major pharmaceutical companies have challenged Australia’s Commissioner of Patents in the Federal Court about the time limits within which an …
Herbert Smith Freehills advises Rosemary Health on Series Seed-2 capital raise
Herbert Smith Freehills’ Venture Capital team has advised Rosemary Health on its Series Seed-2 capital raise.Rosemary Health is a telehealth platform …
Nanda Lau to lead Herbert Smith Freehills’ China corporate practice 刘依兰将领导史密夫斐尔中国公司事务
Shanghai partner Nanda Lau has been named Herbert Smith Freehills’ new head of the firm’s China corporate practice, effective 1 May 2021.She replaces …
2021 M&A predictions hold up in first quarter, but challenges remain
Predictions for an active year for Asia Pacific M&A in a new report from global law firm Herbert Smith Freehills are holding up in the first quarter, …
A ‘new normal’ when it comes to the TGA regulation of medical devices?
Key points: In Australia responding to the urgent need for Covid-related medical devices the TGA implemented a number of emergency measures to bring …
Asia Pacific M&A Review 2021
Our eighth annual review of Asia's deal scene assesses the outlook for big-ticket M&A after a turbulent but eventful yearChange is the only constant …
Judicial review and the life sciences and health sectors
The life sciences and healthcare sector is subject to complex regulation, and decisions of Government bodies can have a significant impact on the …
2020 Australian IPO Review: IPOs by the numbers
A challenging year Market conditions in 2020 unfolded like an obstacle course and were significantly impacted by the onset of the Covid-19 pandemic, …
Showing 48 out of 207 results
View more